pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Ella
drug
save

Ella

Marketedupdated 3mo ago
by HRA Pharma LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 4
  • companyEmory University1 co-mentions · 1 sources
  • companyUniversity of Minnesota1 co-mentions · 1 sources
  • tagWomen's Health1 co-mentions · 1 sources
  • tagGene Therapy (AAV)1 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying Ella

  • phase1Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipomarecruitingn=56
  • N/ASIRONA 2 Trial Heart Failure NYHA Class IIIactive not recruitingn=81
  • —Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shockrecruitingn=350
  • phase3A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)completedn=554
  • —Retrospective Kinetic Safety Evaluation of an Intravenous Micellar Excipient Platformnot yet recruitingn=625
  • phase3A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Agerecruitingn=911
  • phase3A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Populationrecruitingn=2,440
  • phase2Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinomarecruitingn=75
more trials →

Patent cliff

source: FDA Orange Book
first barrier falls
Dec 8, 2028
~2.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (8)

  • Jun 12, 2030method-of-use (U-1389)US 84263923.8y
  • Jun 12, 2030method-of-use (U-1657)US 89626033.8y
  • Jun 2, 2030formulationUS 85127453.8y
  • Apr 13, 2030method-of-use (U-2510)US 101596813.6y
  • Apr 13, 2030method-of-use (U-2958)US 107728973.6y
  • Apr 13, 2030method-of-use (U-1821)US 92832333.6y
  • Feb 20, 2029formulationUS 87353802.5y
  • Dec 8, 2028formulationUS 98445102.3y

News(1)

  • Opinion: Telehealth abortion with mifepristone continues, with backup plans still in place
    Restricting telehealth prescribing of mifepristone wouldn't spell the end of telehealth medication abortion, writes OB-GYN Christine Henneberg.
    stat · 3mo ago
brand
Ella
generic
ulipristal acetate
indication
Female Contraception
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 4m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?